Superficial Bladder Cancer

Epidemiology of bladder cancer; bladder cancer as a molecular disease; pathology, cytology and flowcytometry; natural history and prognosis of untreated and treated superficial bladder cancer; prognostic factors back to the future; rationale and principles of intravesical therapy; a critical review of objective response criteria to intravesical therapy; overview on docorubicin and epirubicin; overview on mitomycin C; overview on BCG; biological response modifiers; comparative trials; photodynamic therapy; unresponsive superficial bladder cancer; new drugs and new strategies; quality of life in patients with superficial bladder cancer; followup; the management of TI tumour the conservative approach; the management of TI tumour the aggressive approach; carcinoma in situ.